1. Nilsestuen J, Fink J, Hess D, Volpe J: Selection of device, administration of bronchodilator, and evaluation of response to therapy in mechanically ventilated patients. RespirCare 1999;44:105-13.

  2. Branson RD: Humidification and aerosol therapy during mechanical ventilation. In: MacIntyre NR, Branson RD: Mechanical ventilation. WB Saunders, Philadelphia 2001: 103-29.

  3. Gunther KL, Dorinsky PM, Witek TJ: Pharmacology of respiratory drugs administered by aerosol during mechanical ventilation. In: MacIntyre NR, Branson RD: Mechanical ventilation. WB Saunders, Philadelphia 2001:269-282.

  4. American Association for Respiratory Care. AARC Clinical practice guideline: selection of a device for delivery of aerosol to the lung parenchyma. Respir Care 1996;41(7):647-653.

  5. Everard ML, Devadason SG, LeSouef PN. In vitro assessment of drug delivery through an endotracheal tube using a dry powder inhaler delivery system. Thorax 1996;51(1):75-77.

  6. Gross NJ,. Jenne JW, Hess D. Bronchodilator therapy. In: M.J. Tobin, editor. Principles and Practice of Mechanical Ventilation. McGraw Hill Publishing Co., New York 1994:1077-1123.

  7. Manthous, CA, Hall JB, Schmidt,GA, Wood LDH. Metered-dose inhaler versus nebulized albuterol in mechanically ventilated patients. Am Rev Respir Dis 1993;148:1567-1570.

  8. Manthous CA, Chatila W, Schmidt GA, Hall JB. Treatment of bronchospasm by metered-dose inhaler albuterol in mechanically ventilated patients. Chest 1995;107:210-213.

  9. Dhand R, Jubran A, Tobin MJ. Bronchodilator delivery by metered-dose inhaler in ventilator-supported patients. Am J Respir Crit. Care Med 1995;151:1827-1833.

  10. Dhand R, Duarte AG, Jubran A, Jenne JW, Fink JB, Fahey PJ, Tobin MJ. Dose response to bronchodilator delivered by metered-dose inhaler in ventilator-supported patients. Am J Respir Crit Care Med 1996;154:388-393.

  11. Gay PC, Rodarte JR, Tayyab M, Hubmayr. RD. Evaluation of bronchodilator responsiveness in mechanically ventilated patients. Am. Rev. Respir. Dis 1987;136:880-885.

  12. Gay PC, Patel HG, Nelson SB, Gilles B, Hubmayr RD. Metered dose inhalers for bronchodilator delivery in intubated, mechanically ventilated patients. Chest 1991;99:66-71.

  13. Wegener T, Wretman S, Sandhagen B, Nystrom S-O. Effect of ipratropium bromide aerosol on respiratory function in patients under ventilator treatment. Acta Anesthesiol Scand 1987;31:652-654.

  14. Fernandez A, Lazaro A, Garcia A, Aragon C, Cerda E. Bronchodilators in patients with chronic obstructive pulmonary disease on mechanical ventilation: utilization of metered-dose inhalers. Am Rev Respir Dis 1990;141:164-168. 

  15. Fresoli RP, Smith RM, Young JA, Gotshall SC. Use of aerosol isoproterenol in an anesthesia circuit. Anesth Analg 1968;47:127-132.

  16. Gold, MI. Treatment of bronchospasm during anesthesia. Anesth Analg 1975;54:783-786.

  17. Sprague DH. Treatment of intraoperative bronchospasm with nebulized isoetharine. Anesthesiology 1977;46:222-224.

  18. Bernasconi M, Brandolese R, Poggi R, Manzin E, Rossi. A. Dose-response effects and time course of effects of inhaled fenoterol on respiratory mechanics and arterial oxygen tension in mechanically ventilated patients with chronic airflow obstruction. Intensive Care Med 1990;16:108-114. 

  19. Wilkie RA, Bryan MH. Effect of bronchodilators on airway resistance in ventilator-dependent neonates with chronic lung disease. J Pediatr 1987;111:278-282.

  20. Motoyama EK, Fort MD , Klesh KW, Mutich RL, Guthrie RD. Early onset of airway reactivity in premature infants with bronchopulmonary dysplasia. Am Rev Respir Dis 1987;136:50-57.

  21. Denjean A, Guimaraes H, Migdal M, Miramand JL, Dehann M, Gaultier C. Dose-related bronchodilator response to aerosolized salbutamol (albuterol) in ventilator-dependent premature infants. J Pediatr 1992;120:974-979.

  22. Newman SP. Therapeutic aerosol deposition in man. In Moren F, Dolovich MB, Newhouse MT, Newman SP, editors. Aerosols in Medicine. 2nd revised edition. Elsevier. Amsterdam 1993: 375-399.

  23. Fuller HD, Dolovich MB, Posmituck G, Wong W Pack, Newhouse MT. Pressurized aerosol versus jet aerosol delivery to mechanically ventilated patients: comparison of dose to the lungs. Am Rev Respir Dis 1990;141:440-444.

  24. Thomas SHL, O’Doherty MJ, Fidler HM, Page CJ, Treacher DF, Nunan TO. Pulmonary deposition of a nebulized aerosol during mechanical ventilation. Thorax 1993;48:154-159.

  25. MacIntyre NR, Silver RM, Miller CW, Schuler F, Coleman ER. Aerosol delivery in intubated, mechanically ventilated patients. Crit Care Med 1985;13:81-84.

  26. O’Riordan TG, Palmer LB, Smaldone GC. Aerosol deposition in mechanically ventilated patients: optimizing nebulizer delivery. Am J Respir Crit Care Med 1994;149:214-219.

  27. Fok TF, Monkman S, Dolovich M, Gray S, Coates G, Paes B, et al. Efficiency of aerosol medication delivery from a metered dose inhaler versus jet nebulizer in infants with bronchopulmonary dysplasia. Pediatric Pulmonol 1996;21:301 309.

  28. Fuller HD, Dolovich MB, Turpie FH, Newhouse MT. Efficiency of bronchodilator aerosol delivery to the lungs from the metered dose inhaler in mechanically ventilated patients: a study comparing four different actuator devices. Chest 1994;105:214-218.

  29. Crogan SJ, Bishop MJ. Delivery efficiency of metered dose aerosols given via endotracheal tubes. Anesthesiology 1989;70:1008-1010.

  30. Dhand R: Special problems in aerosol delivery: Artificial airways.RespirCare 2000;45:636-45

  31. O’Riordan TG, Greco MJ, Perry RJ, Smaldone GC. Nebulizer function during mechanical ventilation. Am Rev Respir Dis 1992;145:1117-1122. 30

  32. O’Doherty MJ, Thomas SHL, Page CJ, Treacher DF, Nunan TO. Delivery of a nebulized aerosol to a lung model during mechanical ventilation: effect of ventilator settings and nebulizer type, position, and volume of fill. Am Rev Respir Dis 1992;146:383-388. 31

  33. Diot P, Morra L, Smaldone GC. Albuterol delivery in a model of mechanical ventilation: comparison of metered-dose inhaler and nebulizer efficiency. Am J Respir Crit Care Med 1995;152:1391-1394. 32

  34. Hughes JM, Saez J. Effects of nebulizer mode and position in a mechanical ventilator circuit on dose efficiency. Respir Care 1987;32:1131-1135. 33

  35. McPeck M, O’Riordan TG, Smaldone GC. Predicting aerosol delivery to intubated patients: influence of choice of mechanical ventilator on nebulizer efficiency. Respir Care 1993;38:887-895. 34

  36. Fink JB, Dhand R, Duarte AG, Jenne JW, Tobin MJ. Deposition of aerosol from metered-dose inhaler during mechanical ventilation: an in vitro model. Am J Respir Crit Care Med 1996;154:382-387. 35

  37. Bishop MJ, Larson, RP, Buschman DL. Metered dose inhaler aerosol characteristics are affected by the endotracheal tube actuator/ adapter used. Anesthesiology 1990;73:1263-1265. 36

  38. Ahrens RC, Ries RA, Popendorf W, Wiese JA. The delivery of therapeutic aerosols through endotracheal tubes. Pediatric Pulmonol. 1986; 2:19-26. 37

  39. Garner SS, Wiest DB, Bradley JW. Albuterol delivery by metered-dose inhaler with a pediatric mechanical ventilatory circuit model. Pharmacotherapy 1994;14:210-214. 38

  40. Newhouse MT, Fuller HD. Rose is a rose is a rose? Aerosol therapy in ventilated patients: nebulizers versus metered dose inhalers- a continuing controversy (editorial). Am Rev Respir Dis 1993;148:1444-1446. 39

  41. Wollam PJ, Kasper CL, Bishop MJ, Pierson DJ. Prediction and assessment of bronchodilator response in mechaniclaly ventilated patients. Respir Care 1994;39(7):730-735. 40

  42. Bates JHT, Milic-Emili J. The flow interruption technique for measuring respiratory resistance. J Crit Care1991;6:227-238. 41

  43. Bates JHT, Rossi A, Milic-Emili J. Analysis of the behaviour of the respiratory system with constant inspiratory flow. J Appl Physiol 1985;58:1840-1848. 42

  44. Jackson AC, Milhorn HT Jr, Norman JR. A reevaluation of the interrupter technique for airway resistance measurement. J Appl Physiol 1974;36:264-268. 43

  45. Pepe PE, Marini JJ. Occult positive end-expiratory pressure in mechanically ventilated patients with airflow obstruction. Am Rev Respir Dis 1982;126:166-170. 44

  46. Alvine GF, Rodgers P, Fitzsimmons KM, Ahrens RC. Disposable jet nebulizers: how reliable are they? Chest 1992;101:16-19. 45

  47. Cameron D, Clay M, Silverman M. Evaluation of nebulizers for use in neonatal ventilator circuits. Crit Care Med 1990;18:866-870. 46

  48. Beaty CD, Ritz RH, Benson MS. Contínuous in-line nebulizers complicate pressure support ventilation. Chest 1989;96:1360-1363. 47

  49. Silverglade A. Cardiac toxicity of aerosol propellants. JAMA 1972; 222:827-829. 48

  50. Dhand R, Tobin MJ: Inhaled Bronchodilator Therapy in MechanicallyVentilated PatientsAm J Respir Crit Care Med Vol. 156. pp. 3–10, 1997

  51. Op´t Holt TB:Aerosol Therapy during mechanical ventilation. AARC Times. July 2000: 18-24

  52. Marik P, Hogan J, Krikorian J: A comparison of bronchodilator therapy delivered by nebulization and metered-dose inhaler in mechanically ventilated patients. Chest 1999;115:1653-6.

  53. Diot P, Morra L, Smaldone GC. Albuterol delivery in a model of mechanical ventilation: comparison of metered-dose inhaler and nebulizer efficiency. Am J Respir Crit Care Med 1995; 152:1391-1394

  54. Hindle M, Chrystyn H. Determination of the relative bioavailability of salbutamol to the lung following inhalation. Br J Clin Pharmacol 1992; 34:311-315

  55. Jarvie DR, Thompson AM, Dyson EH. Laboratory and clinical features of self-poisoning with salbutamol and terbutaline. Clin Chim Acta 1987; 168:313-322

  56. Duarte AC, Dhand R, Reid R, et al. Serum albuterol levels in mechanically ventilated patients and healthy subjects after metered-dose inhaler administration. Am J Respir Crit Care Med 1996; 154:1658-1663

  57. Jones A, Rowe B, Peters J, Camargo C, Hammarquist C. Inhaled beta-agonists for asthma in mechanically ventilated patients (Cochrane Review). In: The Cochrane Library, Issue 1, 2001. Oxford: Update Software.

  58. Ballard RD, Bogin RM, Pak J. Assessment of bronchodilator response to a beta-adrenergic delivered from an untrasonic nebulizer, Chest 1991;100(2):410-415.70

  59. Thomas SHL, O’Doherty MJ, Page CJ, Treacher DF, Nunan TO. Delivery of ultrasonic nebulized aerosols to a lung model during mechanical ventilation. Am Rev Respir Dis 1993;148(4):872-877.

  60. Pallares DE, Pilarski BR, Rodriguez JL, Leickly FE. A comparison of bronchodilator response to albuterol delivered by untrasonic versus jet nebulization in moderate to severe asthma. Ann Allergy Asthma Immunol 1996;77(4):292-297.

  61. Holt WJ, Greenspan JS, Antunes MJ, Cullen JA, Spitzer AR, Wiswell TE. Pulmonary response to an inhaled bronchodilator in chronically ventilated preterm infants with suspected airway reactivity. Respir Care 1995;40(2):145-151.

  62. Shah V, Ohlsson A, Halliday HL, Dunn MS: Early administration of inhaled corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonates (Cochrane Review). In: The Cochrane  Library, Issue 1, 2001. Oxford: Update Software.

  63. Palmer LB, Smaldone GC, Simon SR, O´riordan TG, Cuccia A: Aerosolized antibiotics in mechanically ventilated patients: Delivery and response(Crit Care Med 1998; 26:31-39).

  64. Goldstein I, Wallet F, Robert J, Becquemin MH, Marquette CH-H, et al: Lung Tissue Concentrations of Nebulized Amikacin during Mechanical Ventilation in Piglets with Healthy Lungs. Am. J. Respir. Crit. Care Med.2002;165:171-175

  65. Ware LB, Matthay MA: The acute respiratory distress syndrome.New Engl J Med 342:1334-49.

  66. Anzueto A, Baughman RP, Guntupalli KK, et al. Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome. N Engl J Med 1996;334:1417-21.

  67. Fulkerson WJ, MacIntyre N, Stamler J, Crapo JD. Pathogenesis and treatment of the adult respiratory distress syndrome. Arch Intern Med1996;156:29-38.

  68. Rossaint R, Falke KJ, López F, Slama K, Pison U, Zapol WM. Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med1993;328:399-405.

  69. Dellinger RP, Zimmerman JL, Taylor RW, et al. Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: results of a randomized phase II trial. Crit Care Med 1998;26:15-23.

  70. Payen D, Vallet B, Genoa Group. Results of the French prospective multicentric randomized double-blind placebo-controlled trial on inhaled nitric oxide in ARDS. Intensive Care Med 1999;25:Suppl:S166. abstract.

  71. Hess D: Heliox and inhaled nitric oxide. In: MacIntyre NR, Branson RD: Mechanical ventilation. WB Saunders, Philadelphia 2001:454-80

  72. Brion LP, Primhak RA, Yong W: Aerosolized diuretics for preterm infants with (or developing) chronic lung disease (Cochrane Review). In: The Cochrane Library, Issue 1, 2001. Oxford: Update Software.

  73. Fiel SB: History and Evolution of Aerosolized Therapeutics.Overview and Introduction. CHEST 2001; 120:87S–88S.

  74. Manthous CA: Aerosols for the intubated. Cultivating the rose.Chest.1997;112:304




 Haga su consulta por tema